Registration
ALSTON & BIRD LLP for BIOGEN, INC.
Firm
Client
Income
—
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues regarding promotion of biosimilars.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELINOR HILLER New | Senior Advisor, Office of the Administrator, CMS; Director, Medicare Parts C and D Analysis Group, Office of Legislation, CMS. |
| Y. BRIAN LEE New | Legislative Intern, Rep. Doug Lamborn (R-CO) |
| JANE LUCAS New | Special Assistant to the President, White House Office of Legislative Affairs; Principal Deputy Director, IOS-Office of Health Reform, HHS; Legislative Director, Sen. John Thune (R-SD). All lobbying activities conducted in compliance with EO 13770. |
| TIMOTHY P TRYSLA New | Senior Policy Advisor, CMS |
Medical/Disease Research/Clinical Labs MED
Issues regarding promotion of biosimilars.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELINOR HILLER New | Senior Advisor, Office of the Administrator, CMS; Director, Medicare Parts C and D Analysis Group, Office of Legislation, CMS. |
| Y. BRIAN LEE New | Legislative Intern, Rep. Doug Lamborn (R-CO) |
| JANE LUCAS New | Special Assistant to the President, White House Office of Legislative Affairs; Principal Deputy Director, IOS-Office of Health Reform, HHS; Legislative Director, Sen. John Thune (R-SD). All lobbying activities conducted in compliance with EO 13770. |
| TIMOTHY P TRYSLA New | Senior Policy Advisor, CMS |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.